Search research articles
Contact Us
Filters
Showing results (1-10 of 67) with videos related to
Page
of 7
Sort By:
Anti-Cancer Drugs
|
January 16, 1999
Economic evaluation of cancer treatments: methodological and practical issues
C A Uyl-de Groot, C R Touw
Nederlands Tijdschrift Voor Geneeskunde
|
January 1, 1994
[Costs of autologous bone marrow transplantation in non-Hodgkin lymphoma and acute leukemia]
C A Uyl-de Groot, F F Rutten
European Journal of Cancer (Oxford, England : 1990)
|
August 10, 2000
Economics and health-related quality of life in antiemetic therapy: recommendations for trial design
C A Uyl-de Groot, S Wait, I Buijt
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1996
An economic model to assess the savings from a clinical application of haematopoietic growth factors
C A Uyl-de Groot, E Vellenga, F F Rutten
Pharmacoeconomics
|
June 6, 1996
Colony-stimulating factors and peripheral blood progenitor cell transplantation. Benefits and costs
C A Uyl-de Groot, P C Huijgens, F F Rutten
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Measurement and valuation of quality of life in economic appraisal of cancer treatment
C A Uyl-de Groot, F F Rutten, G J Bonsel
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Peripheral blood progenitor cell transplantation mobilised by r-metHuG-CSF (filgrastim); a less costly alternative to autologous bone marrow transplantation
C A Uyl-de Groot, D J Richel, F F Rutten
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Economic evaluation alongside cancer trials: methodological and practical aspects
G J Bonsel, F F Rutten, C A Uyl-de Groot
Journal of Hematotherapy & Stem Cell Research
|
January 25, 2000
Stem cell transplantations in patients with malignant lymphoma: costs in a Dutch university hospital in the period 1984-1995
C A Uyl-de Groot, G J Ossenkoppele, I Buijt, et al.
Multiple Sclerosis and Related Disorders
|
January 12, 2020
Patient needs and preferences in relapsing-remitting multiple sclerosis: A systematic review
L A Visser, C Louapre, C A Uyl-de Groot, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 67) with videos related to
Sort By:
Page
of 7
Anti-Cancer Drugs
|
January 16, 1999
Economic evaluation of cancer treatments: methodological and practical issues
C A Uyl-de Groot, C R Touw
Nederlands Tijdschrift Voor Geneeskunde
|
January 1, 1994
[Costs of autologous bone marrow transplantation in non-Hodgkin lymphoma and acute leukemia]
C A Uyl-de Groot, F F Rutten
European Journal of Cancer (Oxford, England : 1990)
|
August 10, 2000
Economics and health-related quality of life in antiemetic therapy: recommendations for trial design
C A Uyl-de Groot, S Wait, I Buijt
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1996
An economic model to assess the savings from a clinical application of haematopoietic growth factors
C A Uyl-de Groot, E Vellenga, F F Rutten
Pharmacoeconomics
|
June 6, 1996
Colony-stimulating factors and peripheral blood progenitor cell transplantation. Benefits and costs
C A Uyl-de Groot, P C Huijgens, F F Rutten
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Measurement and valuation of quality of life in economic appraisal of cancer treatment
C A Uyl-de Groot, F F Rutten, G J Bonsel
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Peripheral blood progenitor cell transplantation mobilised by r-metHuG-CSF (filgrastim); a less costly alternative to autologous bone marrow transplantation
C A Uyl-de Groot, D J Richel, F F Rutten
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Economic evaluation alongside cancer trials: methodological and practical aspects
G J Bonsel, F F Rutten, C A Uyl-de Groot
Journal of Hematotherapy & Stem Cell Research
|
January 25, 2000
Stem cell transplantations in patients with malignant lymphoma: costs in a Dutch university hospital in the period 1984-1995
C A Uyl-de Groot, G J Ossenkoppele, I Buijt, et al.
Multiple Sclerosis and Related Disorders
|
January 12, 2020
Patient needs and preferences in relapsing-remitting multiple sclerosis: A systematic review
L A Visser, C Louapre, C A Uyl-de Groot, et al.
Page
of 7